Heat-Shock Protein 70 Overexpression in Adipose-Derived Stem Cells Enhances Fat Graft Survival. 2017

Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
From the *Department of Dermatology, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan; †Department of Plastic Surgery, ‡Department of Emergency, Xijing Hospital; and §Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shannxi, China.

BACKGROUND Autologous fat grafting is a prevalent technique used for soft-tissue augmentation; however, the poor survival rate of the grafted tissue remains a drawback of this method. Although adipose-derived stem cells (ASCs) are an attractive candidate for enhancing graft retention, the poor posttransplantation viability of these cells limits their application. Here we investigated whether overexpression of the antiapoptotic protein heat-shock protein 70 (Hsp70) could enhance ASCs' therapeutic potential for fat transplant survival. METHODS Recombinant adenoviral vectors were used to overexpress Hsp70 in ASCs isolated from a healthy woman. The Hsp70 expression was assessed by quantitative real-time polymerase chain reaction and Western blot analyses. The adipose tissue granules aspirated from another woman were mixed with ASCs expressing green fluorescent protein (GFP)-tagged Hsp70 (group A) or GFP alone (group B), untreated ASCs (group C), and phosphate-buffered saline (group D). Fat mixtures were then injected subcutaneously into the backs of nude mice, and graft survival was compared after 3 months. RESULTS Adipose-derived stem cells transduced with recombinant adenoviral vectors exhibited significantly increased Hsp70 expression in vitro. Meanwhile, weight retention analyses demonstrated that fat grafts using the group A cell population exhibited significantly higher survival rates than the other treatment groups in vivo. Moreover, histological analyses revealed that fat grafts containing GFP-Hsp70-expressing ASCs yielded significantly lower levels of tissue fibrosis and fat cysts/vacuoles, higher capillary densities, and increased numbers of viable adipocytes than the control groups. CONCLUSIONS Our data indicate that Hsp70 overexpression enhances the efficacy of ASC therapy by improving the survival and quality of the transplanted fat tissues.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
October 2022, International journal of molecular sciences,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
March 2023, Plastic and reconstructive surgery,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
April 2023, Aesthetic plastic surgery,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
April 2017, Stem cells and development,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
October 2023, Aesthetic plastic surgery,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
January 1999, Kidney international,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
September 2004, Ugeskrift for laeger,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
October 2023, Aesthetic plastic surgery,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
August 2013, Annals of plastic surgery,
Hao Feng, and Lihong Qiu, and Teng Zhang, and Houyou Yu, and Xianjie Ma, and Yingjun Su, and Hui Zheng, and Yong Wang, and Chenggang Yi
August 2012, Plastic and reconstructive surgery,
Copied contents to your clipboard!